Richard B. Pollard

13.7k citations

268 papers · 10.4k indexed · 2 hit papers · h-index 50

Epidemiology top 0.5%
Virology top 0.1%
Infectious Diseases top 0.2%
Immunology top 0.5%
Molecular Biology top 10%

Co-authors: Thomas C. Merigan Fujio Suzuki Makiko Kobayashi Kenneth H. Rand Mostafa Nokta Gregory K. Robbins David M. Asmuth T. Utsunomiya
Topics: HIV Research and Treatment (112 papers)HIV/AIDS drug development and treatment (60 papers)Immune Cell Function and Interaction (49 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: New England Journal of Medicine The Lancet JAMA
Partner nations: United States Japan United Kingdom

In The Last Decade

Richard B. Pollard

264 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

2009 478 citations Richard B. Pollard et al. profile →
Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active Hepatitis

1976 370 citations Richard B. Pollard, Thomas C. Merigan et al. profile →

Peers

Countries citing papers authored by Richard B. Pollard

Since Specialization

Citations

This map shows the geographic impact of Richard B. Pollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Pollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Pollard more than expected).

Fields of papers citing papers by Richard B. Pollard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Pollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Pollard. The network helps show where Richard B. Pollard may publish in the future.

Co-authorship network of co-authors of Richard B. Pollard

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Pollard. A scholar is included among the top collaborators of Richard B. Pollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Pollard. Richard B. Pollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Short Communication: HIV ⁺ Viremic Slow Progressors Maintain Low Regulatory T Cell Numbers in Rectal Mucosa but Exhibit High T Cell Activation 2012 ·AIDS Research and Human Retroviruses ·(unknown),Peter W. Hunt,J. William Critchfield,(unknown),Juan Carlos García‐Ruiz,Richard B. Pollard,Ma Somsouk,Steven G. Deeks,Barbara L. Shacklett	12
2	Mitochondrial Genomics and CD4 T-Cell Count Recovery After Antiretroviral Therapy Initiation in AIDS Clinical Trials Group Study 384 2011 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown),David C. Samuels,Gregory K. Robbins,(unknown),Jeffrey A. Canter,Richard B. Pollard,David W. Haas,Robert W. Shafer,Spyros A. Kalams,Deborah G. Murdock,Marylyn D. Ritchie,Todd Hulgan	17
3	Immunodominant HIV-Specific CD8 ⁺ T-Cell Responses Are Common to Blood and Gastrointestinal Mucosa, and Gag-Specific Responses Dominate in Rectal Mucosa of HIV Controllers 2010 ·Journal of Virology ·April L. Ferre,(unknown),Peter W. Hunt,Megan M. Morris,Juan Carlos García‐Ruiz,Richard B. Pollard,Hal F. Yee,Jeffrey N. Martin,Steven G. Deeks,Barbara L. Shacklett	49
4	Age-Related Changes in Plasma Concentrations of the HIV Protease Inhibitor Lopinavir 2010 ·AIDS Research and Human Retroviruses ·Keith W. Crawford,John Spritzler,Robert C. Kalayjian,Teresa L. Parsons,Alan Landay,Richard B. Pollard,(unknown),Michael M. Lederman,Charles Flexner	29
5	Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy 2008 ·Journal of Interferon & Cytokine Research ·Richard T. Davey,Peter Pertel,Alice Benson,Delanie J. Cassell,Brian Gazzard,Mark Holodniy,Jacob Lalezari,Yves Lévy,Ronald T. Mitsuyasu,Frank J. Palella,Richard B. Pollard,Prabhu Rajagopalan,Michael S. Saag,Robert A. Salata,Beverly E. Sha,Shurjeel Choudhri	5
6	Lowering the Dose of Hydroxyurea Minimizes Toxicity and Maximizes Anti-HIV Potency 2005 ·AIDS Research and Human Retroviruses ·Franco Lori,Richard B. Pollard,Lucia Whitman,Nyasha Bakare,Gary Blick,(unknown),Andrea Foli,D. M. Peterson,Alan M. Tennenberg,Shannon Schrader,Bruce Rashbaum,Charles Farthing,(unknown),D. B. Norris,(unknown),Ian Frank,(unknown),(unknown),David M. Asmuth,Julianna Lisziewicz	9
7	Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 248) 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mary Vogler,Hedy Teppler,Rebecca Gelman,Fred Valentine,Michael M. Lederman,Roger J. Pomerantz,Richard B. Pollard,(unknown),Charles J. Gonzalez,Kathleen Squires,Ian Frank,Donna Mildvan,(unknown),Barbara Schock	15
8	A Phase II Randomized Study of the Virologic and Immunologic Effect of Zidovudine + Stavudine versus Stavudine Alone and Zidovudine + Lamivudine in Patients with >300 CD4 Cells Who Were Antiretroviral Naive (ACTG 298) 2002 ·AIDS Research and Human Retroviruses ·Richard B. Pollard,Camlin Tierney,Diane V. Havlir,Pablo Tebas,Lawrence Fox,Laura Smeaton,Douglas D. Richman,Gerald Friedland	7
9	An Increase in the Susceptibility of Burned Patients to Infectious Complications Due to Impaired Production of Macrophage Inflammatory Protein 1α 2002 ·The Journal of Immunology ·Makiko Kobayashi,Hitoshi Takahashi,Arthur P. Sanford,David N. Herndon,Richard B. Pollard,Fujio Suzuki	36
10	Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals 2001 ·AIDS ·Mostafa Nokta,Xiao-Dong Li,Joan E. Nichols,(unknown),Anna M. Pou,David M. Asmuth,Richard B. Pollard	30
11	Effect of Therapeutic Immunization with HIV Type 1 Recombinant Glycoprotein 160 ImmunoAG Vaccine in HIV-Infected Individuals with CD4 ⁺ T Cell Counts of ≥500 and 200-400/mm ³ (AIDS Clinical Trials Group Study 246/946) 2001 ·AIDS Research and Human Retroviruses ·Smriti Kundu‐Raychaudhuri,Anne Sevin,Patrick Kilgo,Mostafa Nokta,Richard B. Pollard,Thomas C. Merigan	8
12	Effect of Didanosine, Stavudine, and Hydroxyurea Therapy on Apoptosis in CD45RA+ and CD45RO+ T Lymphocyte Subpopulations 1999 ·AIDS Research and Human Retroviruses ·Mostafa Nokta,(unknown),Joan E. Nichols,(unknown),Richard B. Pollard	8
13	Randomized double-blind study of combination therapy with didanosine and stavudine in HIV-infected individuals 1997 ·Antiviral Therapy ·Richard B. Pollard	2
14	Inhibition of burn‐associated suppressor cell generation by glycyrrhizin through the induction of contrasuppressor T cells 1993 ·Immunology and Cell Biology ·Makio Kobayashi,David A. Schmitt,T. Utsunomiya,Richard B. Pollard,Fumio Suzuki	22
15	Human Immunodeficiency Virus Replication: Modulation by Cellular Levels of cAMP 1992 ·AIDS Research and Human Retroviruses ·Mostafa Nokta,Richard B. Pollard	45
16	Metabolic Interaction of Recombinant Interferon-β and Zidovudine in AIDS Patients 1991 ·Journal of Interferon Research ·Mostafa Nokta,(unknown),(unknown),Ahmed Ezzat Ahmed,Richard B. Pollard	12
17	Patterns of Interferon-γ Production by Peripheral Blood Mononuclear Cells from Patients with Human Immunodeficiency Virus Infection 1990 ·Journal of Interferon Research ·Mostafa Nokta,Richard B. Pollard	15
18	Macrophage involvement in the protective effect of carboxyethylgermanium sesquioxide (GE-132) against murine ascites tumours 1986 ·Fumihiko Suzuki,Randy R. Brutkiewicz,Richard B. Pollard	4
19	Prevention of Suppressed Interferon Gamma Production in Thermally Injured Mice by Administration of a Novel Organogermanium Compound, Ge-132 1984 ·Journal of Interferon Research ·Fujio Suzuki,Richard B. Pollard	16
20	Treatment of cytomegalovirus infection with intravenous ARA-A 1978 ·Investigative Ophthalmology & Visual Science ·P. R. Egbert,Richard B. Pollard,(unknown),T. C. Merigan	1

About Richard B. Pollard

Richard B. Pollard is a scholar working on Virology, Infectious Diseases and Immunology, having authored 268 papers that have together received 10.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (112 papers), HIV/AIDS drug development and treatment (60 papers) and Immune Cell Function and Interaction (49 papers). The work is most often cited by research in Virology (3.7k citations), Infectious Diseases (3.7k citations) and Immunology (2.9k citations). Richard B. Pollard has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Thomas C. Merigan, Fujio Suzuki, Makiko Kobayashi, Kenneth H. Rand, Mostafa Nokta, Gregory K. Robbins, David M. Asmuth, T. Utsunomiya, Peter B. Gregory and William H. Robinson. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact